These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29151964)

  • 1. ITGBL1 Predicts a Poor Prognosis and Correlates EMT Phenotype in Gastric Cancer.
    Li R; Zhuang C; Jiang S; Du N; Zhao W; Tu L; Cao H; Zhang Z; Chen X
    J Cancer; 2017; 8(18):3764-3773. PubMed ID: 29151964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive analysis of potential gastric cancer prognostic biomarker ITGBL1 associated with immune infiltration and epithelial-mesenchymal transition.
    Wang Z; Fu L; Zhang J; Ge Y; Guo C; Wang R; Deng M; Wang Q; Wang Z
    Biomed Eng Online; 2022 May; 21(1):30. PubMed ID: 35596183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-1 from cancer-associated fibroblasts induces epithelial-mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer.
    Chong Y; Tang D; Xiong Q; Jiang X; Xu C; Huang Y; Wang J; Zhou H; Shi Y; Wu X; Wang D
    J Exp Clin Cancer Res; 2016 Nov; 35(1):175. PubMed ID: 27836001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ITGBL1 promotes EMT, invasion and migration by activating NF-κB signaling pathway in prostate cancer.
    Li W; Li S; Yang J; Cui C; Yu M; Zhang Y
    Onco Targets Ther; 2019; 12():3753-3763. PubMed ID: 31190876
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulatory Mechanism of ITGBL1 in the Metastasis of Colorectal Cancer.
    Qi L; Song F; Ding Y
    Front Oncol; 2020; 10():259. PubMed ID: 32211321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer.
    Qiu X; Feng JR; Qiu J; Liu L; Xie Y; Zhang YP; Liu J; Zhao Q
    Biomed Pharmacother; 2018 Aug; 104():172-180. PubMed ID: 29772438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer.
    Matsuyama T; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kawano T; Uetake H; Goel A
    Mol Cancer; 2019 Feb; 18(1):19. PubMed ID: 30717807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITGBL1 promotes anoikis resistance and metastasis in human gastric cancer via the AKT/FBLN2 axis.
    Shen K; Xia W; Wang K; Li J; Xu W; Liu H; Yang K; Zhu J; Wang J; Xi Q; Shi T; Li R
    J Cell Mol Med; 2024 Feb; 28(4):e18113. PubMed ID: 38332530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma.
    Huang W; Yu D; Wang M; Han Y; Lin J; Wei D; Cai J; Li B; Chen P; Zhang X
    Cell Prolif; 2020 Jul; 53(7):e12836. PubMed ID: 32537856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropilin-1 predicts poor prognosis and promotes tumor metastasis through epithelial-mesenchymal transition in gastric cancer.
    Jin Q; Ren Q; Chang X; Yu H; Jin X; Lu X; He N; Wang G
    J Cancer; 2021; 12(12):3648-3659. PubMed ID: 33995640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic downregulated ITGBL1 promotes non-small cell lung cancer cell invasion through Wnt/PCP signaling.
    Gan X; Liu Z; Tong B; Zhou J
    Tumour Biol; 2016 Feb; 37(2):1663-9. PubMed ID: 26307393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ITGBL1 promotes gastric cancer cell proliferation and invasion via Akt signal pathway.
    Yin FY; Qi HP; Qiao H; Lv XH; Tan HH
    Front Biosci (Landmark Ed); 2021 Jan; 26(4):682-691. PubMed ID: 33049688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
    Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
    J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of LKB1 is associated with epithelial-mesenchymal transition and led to an unfavorable prognosis in gastric cancer.
    Hu M; Zhao T; Liu J; Zou Z; Xu Q; Gong P; Guo H
    Hum Pathol; 2019 Jan; 83():133-139. PubMed ID: 30171989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
    Feng Y; Zhang Q; Wang J; Liu P
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of ITGBL1 predicts poor prognosis and promotes chemoresistance in ovarian cancer.
    Song J; Yang P; Lu J
    Cancer Biomark; 2020; 27(1):51-61. PubMed ID: 31683459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TBL1XR1 Is Highly Expressed in Gastric Cancer and Predicts Poor Prognosis.
    Liu F; He Y; Cao Q; Liu N; Zhang W
    Dis Markers; 2016; 2016():2436518. PubMed ID: 27672238
    [No Abstract]   [Full Text] [Related]  

  • 18. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
    Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
    Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PODXL, negatively regulated by KLF4, promotes the EMT and metastasis and serves as a novel prognostic indicator of gastric cancer.
    Zhang J; Zhu Z; Wu H; Yu Z; Rong Z; Luo Z; Xu Y; Huang K; Qiu Z; Huang C
    Gastric Cancer; 2019 Jan; 22(1):48-59. PubMed ID: 29748877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.